EHA2024 Hybrid Congress

Date: June 13-16, 2024
Location: Madrid, Spain
Format: Hybrid

Recent advances in lymphoid and myeloid malignancies

Date: September 14-15, 2024
Location: Almaty, Kazakhstan
Format: In-person

Bridging between functional and genomic precision medicine

Date: September 25-27, 2024
Location: Copenhagen, Denmark
Format: In-person

Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT)

Date: October 2-5, 2024
Location: London, United Kingdom

EHA's pilot preceptorship on Sickle Cell Disease.

Dates: October 16-18, 2024
Location: Paris, France
Format: In-person

New aspects in diagnostic choices and treatment options of hematological malignancies

Date: October 18-20, 2024
Location: Tbilisi, Georgia
Format: In-person

Myeloproliferative disorders

Date: November 14-15, 2024
Location: Varna, Bulgaria
Format: Hybrid

Bone marrow failure and leukemia predisposition syndromes

Date: November 15-17, 2024
Location: Paris, France
Format: In-person

7th European CAR T-cell Meeting

Dates: February 6-8, 2025
Location: Strasbourg, France
Format: Hybrid

EHA Research Conference 2025

"Transcriptional control and chromatin alterations in normal and abnormal hematopoiesis"

Date: March 17-20, 2025
Location: Málaga, Spain
Format: In-person

Lymphoid Malignancies

Date: April 5-6, 2025
Location: Hong Kong
Format: In-person

Date: April 2025
Location: Skopje, North Macedonia
Format: Hybrid

EHA-SWG Scientific Meeting on Recent Advances in the Pathogenesis and Treatment of Secondary Acute Myeloid Leukemias


Date: April 25-26, 2025
Location: to be announced
Format: In-person

EHA2025 Congress

Date: June 12-15, 2025
Location: Milan, Italy
Format: Hybrid